Latest Breaking News On - Executive officer lindy durrant - Page 1 : comparemela.com

Scancell interim loss narrows amid finance gain on derivative

Scancell Holdings PLC on Tuesday reported a narrowed loss as it gained on the revaluation of derivative liability. The Oxford, England-based developer of immunotherapies for treatment of cancer and.

Scancell approved by MHRA to add new cohort to Scope trial

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease said - Receives approval from UK s Medicines & Healthcare products Regulatory.

TRADING UPDATES: Scancell trial progresses; OptiBiotix inks new deal

Scancell trial progresses; OptiBiotix inks new deal

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Scancell Holdings PLC - Nottingham,.

Scancell appoints Prenetics' Sath Nirmalananthan as new CFO

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Hires Sath Nirmalananthan to be chief financial officer, starting immediately. Nirmalananthan previously was CFO.